Our story
OVER 75 YEARS IN BUSINE
1943
It was 1943; WWII was taking place as the rising pharmaceutical industry was being established in Mexico. The Mexican Institute of Social Security (IMSS) was created with the mission of providing healthcare to Mexicans whose needs had already become a national priority. Given this background, Don Antonio López de Silanes Salinas, came up with the creation of a capital stock pharmaceutical laboratory that would answer to the growing demands of the population, so he founded "Laboratorios Silanes Corp." on November 4th, 1943.
Since its inception, Silanes Laboratories has recorded an accelerated growth through the sale and manufacture of vitamins and pain-relieving medication. However, it should be noted that, in 1957, a line of medication, which will grow considerably in the coming decades and which nowadays make up for one of the main company success stories, had its beginnings: antidiabetics.
At the beginning of the 21st century, Silanes opened its industrial plant in Toluca, which is currently undergoing a process of globalization, innovation and institutionalization hoping to continue growing in competitiveness and productivity. With over 74 years in business, today it is a sound company that has managed to evolve according to the QA and innovation requirements demanded nowadays. At the same time, it keeps a tradition of trust and commitment with the different stakeholders such as physicians, the health sector, collaborators, clients, associates, researchers, suppliers, authorities, etc. They seek to provide the world with better health solutions on a daily basis
WE ARE AN INNOVATIVE COMPANY
10%
OF OUR SALES
WE ALLOCATE TO
RESEARCH AND DEVELOPMENT
In addition to having more than 80 pharmaceutical products in our portfolio, including a recognized range of oral antidiabetics, the Bioclon Silanes Institute, the company's biotechnology division, generates unique antivenoms worldwide, being the first company in Latin America to be authorized by the Food and Drug Administration to market a drug in the United States. We also have differentiated products for diagnostics and nutraceuticals.
On the other hand, Silanes has a long tradition of social responsibility in the field of health, ranging from support of young practitioners to the donation of medicines. Silanes is currently a signatory of the Global Pact and, for the last seven years, has been branded a Socially Responsible Company seal, which confirms our commitment to ethics, the environment, life quality both in the company and with the community.
